While CCL2 levels were similar for glioma cells co-culture with WT or CD44-/- microglia, IL-6 mRNA levels were reduced by half in glioma cells co-cultured with CD44-/- microglia, compared to WT. This evidence concerns the gene CCL2 and central nervous system cancer.